700 related articles for article (PubMed ID: 29392373)
21. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.
Tang X; Zhou C; Gao J; Duan W; Yu M; Xiao W; Zhang X; Dong H; Wang X; Zhang X
BMC Psychiatry; 2019 Aug; 19(1):254. PubMed ID: 31420036
[TBL] [Abstract][Full Text] [Related]
22. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
Niitsu T; Shirayama Y; Matsuzawa D; Hasegawa T; Kanahara N; Hashimoto T; Shiraishi T; Shiina A; Fukami G; Fujisaki M; Watanabe H; Nakazato M; Asano M; Kimura S; Hashimoto K; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1836-40. PubMed ID: 21930178
[TBL] [Abstract][Full Text] [Related]
23. Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study.
Takeuchi H; Suzuki T; Remington G; Bies RR; Abe T; Graff-Guerrero A; Watanabe K; Mimura M; Uchida H
Schizophr Bull; 2013 Sep; 39(5):993-8. PubMed ID: 23821768
[TBL] [Abstract][Full Text] [Related]
24. Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study.
Zhou Y; Li G; Li D; Cui H; Ning Y
J Psychopharmacol; 2018 May; 32(5):524-532. PubMed ID: 29493377
[TBL] [Abstract][Full Text] [Related]
25. The interplay between BDNF and oxidative stress in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893
[TBL] [Abstract][Full Text] [Related]
26. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
[TBL] [Abstract][Full Text] [Related]
27. An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial.
Pawełczyk T; Grancow-Grabka M; Trafalska E; Szemraj J; Żurner N; Pawełczyk A
Psychopharmacology (Berl); 2019 Sep; 236(9):2811-2822. PubMed ID: 31098654
[TBL] [Abstract][Full Text] [Related]
28. Depressive symptoms in schizophrenia patients: A possible relationship between SIRT1 and BDNF.
Fang X; Chen Y; Wang Y; Ren J; Zhang C
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109673. PubMed ID: 31247244
[TBL] [Abstract][Full Text] [Related]
29. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
Lee BH; Kim YK
Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia.
Riedel M; Müller N; Spellmann I; Engel RR; Musil R; Valdevit R; Dehning S; Douhet A; Cerovecki A; Strassnig M; Möller HJ
Eur Arch Psychiatry Clin Neurosci; 2007 Oct; 257(7):402-12. PubMed ID: 17629725
[TBL] [Abstract][Full Text] [Related]
31. Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia.
Huo L; Zheng Z; Lu X; Wu F; Ning Y; Zhang XY
Front Psychiatry; 2021; 12():641278. PubMed ID: 34239458
[No Abstract] [Full Text] [Related]
32. Omega-3 fatty acids ameliorate cognitive dysfunction in schizophrenia patients with metabolic syndrome.
Tang W; Wang Y; Xu F; Fan W; Zhang Y; Fan K; Wang W; Zhang Y; Zhang C
Brain Behav Immun; 2020 Aug; 88():529-534. PubMed ID: 32304881
[TBL] [Abstract][Full Text] [Related]
33. Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.
Nikolac Perkovic M; Nedic Erjavec G; Zivkovic M; Sagud M; Uzun S; Mihaljevic-Peles A; Kozumplik O; Muck-Seler D; Pivac N
Psychopharmacology (Berl); 2014 Sep; 231(18):3757-64. PubMed ID: 24595507
[TBL] [Abstract][Full Text] [Related]
34. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY
Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116
[TBL] [Abstract][Full Text] [Related]
35. Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics.
González-Pinto A; Mosquera F; Palomino A; Alberich S; Gutiérrez A; Haidar K; Vega P; Barbeito S; Ortiz A; Matute C
Int Clin Psychopharmacol; 2010 Jul; 25(4):241-5. PubMed ID: 20568658
[TBL] [Abstract][Full Text] [Related]
36. Preliminary Associations Between Brain-Derived Neurotrophic Factor, Memory Impairment, Functional Cognition, and Depressive Symptoms Following Severe TBI.
Failla MD; Juengst SB; Arenth PM; Wagner AK
Neurorehabil Neural Repair; 2016 Jun; 30(5):419-30. PubMed ID: 26276123
[TBL] [Abstract][Full Text] [Related]
37. Plasma and serum brain-derived neurotrophic factor (BDNF) levels and their association with neurocognition in at-risk mental state, first episode psychosis and chronic schizophrenia patients.
Heitz U; Papmeyer M; Studerus E; Egloff L; Ittig S; Andreou C; Vogel T; Borgwardt S; Graf M; Eckert A; Riecher-Rössler A
World J Biol Psychiatry; 2019 Sep; 20(7):545-554. PubMed ID: 29938562
[No Abstract] [Full Text] [Related]
38. Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia.
Carlino D; Leone E; Di Cola F; Baj G; Marin R; Dinelli G; Tongiorgi E; De Vanna M
J Psychiatr Res; 2011 Feb; 45(2):273-9. PubMed ID: 20630543
[TBL] [Abstract][Full Text] [Related]
39. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
Zhang XY; Liang J; Chen DC; Xiu MH; Yang FD; Kosten TA; Kosten TR
Psychopharmacology (Berl); 2012 Jul; 222(2):277-84. PubMed ID: 22274000
[TBL] [Abstract][Full Text] [Related]
40. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.
Yang Y; Liu Y; Wang G; Hei G; Wang X; Li R; Li L; Wu R; Zhao J
Psychiatry Res; 2019 Mar; 273():528-536. PubMed ID: 30710808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
